Taken together, these observations suggest that NK cells are becoming activated upon DNAM-1 engagement with ligands on BM myeloma cells, which results in the subsequent downregulation or shedding of the receptor from the NK cell surface. Here, CD226 is linked to plasma cell myeloma.